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Abstract
Background: HIV prevalence among pregnant women in Malawi is 12.6%, and mother-to-child transmission is a
major route of transmission. As PMTCT services have expanded in Malawi in recent years, we sought to determine
uptake of services, HIV-relevant infant feeding practices and mother-child health outcomes.
Methods: A matched-cohort study of HIV-infected and HIV-uninfected mothers and their infants at 18-20 months
post-partum in Zomba District, Malawi. 360 HIV-infected and 360 HIV-uninfected mothers were identified through
registers. 387 mother-child pairs were included in the study.
Results: 10% of HIV-infected mothers were on HAART before delivery, 27% by 18-20 months post-partum. sd-NVP
was taken by 75% of HIV-infected mothers not on HAART, and given to 66% of infants. 18% of HIV-infected
mothers followed all current recommended PMTCT options. HIV-infected mothers breastfed fewer months than
HIV-uninfected mothers (12 vs.18, respectively; p < 0.01). 19% of exposed versus 5% of unexposed children had
died by 18-20 months; p < 0.01. 28% of exposed children had been tested for HIV prior to the study, 76% were
tested as part of the study and 11% were found HIV-positive. HIV-free survival by 18-20 months was 66% (95%CI
58-74). There were 11(6%) maternal deaths among HIV-infected mothers only.
Conclusion: This study shows low PMTCT program efficiency and effectiveness under routine program conditions
in Malawi. HIV-free infant survival may have been influenced by key factors, including underuse of HAART,
underuse of sd-NVP, and suboptimal infant feeding practices. Maternal mortality among HIV-infected women
demands attention; improved maternal survival is a means to improve infant survival.
Background
Mother-to-child transmission (MTCT) of HIV accounts
for 14% of all new HIV infections worldwide [1], and
may occur during pregnancy, labor and delivery or
breastfeeding. In the absence of prevention, rates of
MTCT are estimated to be 25-35 percent [2,3]. In 2007,
the national HIV prevalence rate among pregnant
women in Malawi was 12.6% [4] with an estimated
89,000 HIV-infected children. Survival of these children
is limited with approximately 50% dying before two
years of age [2,4].
Since 2003, the primary prophylaxis regimen within
the Malawian prevention of mother-to-child transmis-
sion (PMTCT) strategy has been single dose nevirapine
(sd-NVP). At the time of study, PMTCT guidelines [2]
in Malawi supported HIV testing and counseling (HTC)
for all women presenting to antenatal clinics (ANC).
HIV-infected women should have WHO clinical staging,
CD4 count if indicated and available, and initiation of
highly active antiretroviral treatment (HAART) for
women in stages III or IV, or in stages I and II if CD4
count <250. All women not initiated on HAART should
be provided sd-NVP during the antenatal period to be
taken at the onset of labor and all HIV-exposed infants
provided with sd-NVP syrup within 72 hours of birth
[2]. Postnatal recommendations for HIV-exposed infants
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in Malawi were exclusive breastfeeding for the first 6
months of life, or if replacement feeding was acceptable,
feasible, affordable, sustainable and safe, avoidance of all
breastfeeding. Mothers were advised to return with the
infant for HIV DNA-PCR testing at 6 weeks and coun-
seling on follow-up HTC up to 18 months.
In 2003, the Ministry of Health (MoH) set a target of
at least 75% of women attending ANC with PMTCT
services by the end of 2010 [5]. By 2007, PMTCT ser-
vices were available in 64% of health facilities [2]. In
2004, an evaluation of the PMTCT program in Thyolo
district in Malawi revealed a progressive loss to follow-
up of HIV-infected mothers; cumulative loss to follow-
up was 55% by the 36 week antenatal visit, 68% by deliv-
ery and 81% by the 6 month post-natal visit [6]. In the
same district, a qualitative study depicted many commu-
nity and provider related operational and cultural bar-
riers hindering the acceptability of the PMTCT program
[7]. Although the provision of basic PMTCT services
has been expanded considerably in Malawi in recent
years, the efficiency and effectiveness of these interven-
tions remain unknown. In Zomba district, where uptake
of PMTCT services by pregnant women appears to be
increasing, monitoring data showed that few HIV-
infected mothers and HIV exposed infants are accessing
HIV treatment, care and support and data on uptake
and effectiveness of PMTCT interventions was limited.
Assessing the quality of PMTCT services and identifying
ways in which delivery of those services could be
improved is essential to address maternal health needs
and prevent MTCT.
Methods
A matched-cohort study of HIV-infected and HIV-unin-
fected mothers and their infants 18-20 months after
their estimated delivery date was conducted between
August and December 2009.
This study was conducted in Zomba district (popula-
tion 670,000) in southern Malawi where 80% of inhabi-
tants are rural [8]. Antenatal surveillance data from
sentinel health centers show that HIV prevalence is
high, ranging from 12% to 34% [4]. Public health ser-
vices are provided at one central hospital, one mission
hospital and 33 health centers, run by the Zomba Dis-
trict Health Office (DHO). Clinical services and medica-
tions are provided by the MOH without user fees. Since
2005, the Zomba DHO in partnership with Dignitas
International, have implemented PMTCT services. By
2007, 22 ANC sites in Zomba District provided PMTCT
services. Zomba District data indicate that 96% of all
women attend at least one ANC visit and that 56% of
deliveries are performed by skilled birth attendants in
health institutions [9].
20 out of 22 sites in the district where PMTCT ser-
vices were provided for at least 18 months were
included in this study. 2 sites, Zomba Central Hospital
and St. Luke’s Mission Hospital, were excluded as
women who gave birth at these district level referral
hospitals may not live in proximity and therefore would
be more difficult to trace, and they may also be a differ-
ent population than those who attend health centres. All
HIV-infected mothers who attended one of the 20 rural
public facilities that provide antenatal services, and had
an estimated delivery date between March 1st and May
31st 2008, were identified through antenatal, delivery
and postnatal facility registers. By reviewing all available
registers, we attempted to capture the entire cohort of
HIV-infected pregnant women in the district. For every
HIV-infected mother, the next registered HIV-unin-
fected mother was identified as a control. 5 other health
centers were excluded during this process since few
(<10) HIV positive women were identified.
Community sensitization meetings were conducted
prior to data collection to inform community leaders
and health facility teams about the study. In addition,
study advertisement posters were displayed at health
centers and in the villages. Health Surveillance Assis-
tants (HSAs) helped trace participants and asked the
identified mother-child pairs to come to the health cen-
tre for interviews. Since equal numbers of HIV-infected
and HIV-uninfected mothers were recruited there was
no association between study participation and HIV sta-
tus. In cases where the mother had died, the child’s pri-
mary caregiver was interviewed. If the mother or the
primary caregiver did not come for interview, the inter-
viewer, accompanied by the HSA, visited the participant
at home for the interview. In cases where study partici-
pants were reported to have moved or died, village
headmen were consulted and village registers reviewed
for verification.
Data collection was conducted by 6 trained female
interviewers through semi-structured interviews using a
standardized questionnaire.The questionnaire adminis-
tered to the mothers included questions regarding
socio-economic demographics, parity, disclosure of HIV
status, partner testing, uptake of PMTCT services from
HTC at ANC to uptake of sd-NVP and HAART, and
feeding options utilized. Information concerning prior
HIV-testing and ARVs was verified through personal
health passports, a small personal paper booklet that
provides a record of clinical encounters. Responses on
uptake of sd-NVP or HAART were verified with avail-
able information in health passports and registers.
When information differed or was missing (e.g. when
mother had died) the information from the registers was
included.
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Mothers and/or children with negative or unknown
HIV status were offered point of care HIV rapid testing.
All testing was done by trained counselors as per the
Malawian MOH guidelines. Mothers and/or children
found HIV-infected were referred to the nearest clinic
which could provide appropriate ART services, including
ongoing care and assessment for ART eligibility.
Data and statistical analysis were conducted using
STATA 9.1 (StataCorp, Texas, USA) and SPSS 17.0
(SPSS, Inc., Chicago, IL, USA). Comparisons between
groups were made using t-tests and exact tests. Relative
risks (RR) as a ratio of two proportions with a confi-
dence level of 95% were derived from two-by-two con-
tingency tables. Reported RR’s are unadjusted, unless
stated otherwise and all variables were considered signif-
icant with a p < 0.05. HIV-free survival by 18-20 months
was calculated as: total number of cohort minus number
of transmissions, deaths and not tested by 18-20 months
divided by total number of cohort minus number not
tested.
This study received ethical approval from the National
Health Science Research Committee in Malawi. Written
informed consent was given by all participants.
Results
Demographics of Mother-Child Pairs
Table 1 provides an overview of mother-child pairs
identified and traced. 360 HIV-infected mothers and
360 HIV-uninfected mothers were identified through all
available registers. 173 HIV-infected and 214 HIV-unin-
fected mothers-child pairs were found and included in
the study. Out of the 720 mother-child pairs traced, 61
had moved out of the area, 265 were not found and 3
were not willing to participate. No significant difference
was found in the proportion of mothers having moved
out of the area or not found (p = 0.09). 6 caregivers
responded for a deceased mother and 40 mothers with
children that had died were included alone. 5 mother-
child pairs were confirmed to have both died.
In this cohort, HIV-infected mothers were older than
HIV-negative mothers; median 29 vs. 24 years of age,
respectively; p = 0.01. HIV-infected mothers were less
likely to have received secondary education than HIV-
uninfected mothers (RR 0.5; 95%CI 0.3-0.8; p = 0.001). No
significant differences were found between HIV-infected
and HIV-uninfected mothers in terms of employment sta-
tus, dwelling type, water source or transport method used,
indicating a uniformly poor community.
14 (9%) HIV-infected mothers identified by registers
denied or did not want to reveal their HIV status. HIV-
infected mothers were four times more likely not to
have disclosed their HIV status to their partners than
HIV-uninfected mothers (RR 3.5; CI 95% 1.3-9.7; p =
0.008) and partners of HIV-infected mothers were less
likely to have gone for HIV testing than partners of
HIV-uninfected mothers (RR 0.7; 95%CI 0.6-0.9; p <
0.001).
Median parity among HIV-infected and HIV-unin-
fected mothers was 4 (IQR1-7) and 2 (IQR 0-5), respec-
tively; p = 0.001. When controlling for age HIV-infected
women were still more likely to have more than 2 chil-
dren than HIV-uninfected women. (age adjusted RR 2.3;
CI 95% 1.3-4.5; p = 0.007).
Uptake of PMTCT services
Tables 2 and 3 give an overview of uptake of PMTCT
services, from HTC at ANC to uptake of sd-NVP and
HAART and feeding options utilized. Mothers reported
to have attended a mean and median of 4 ANC visits
(IQR 1-5) with no difference between HIV-infected and
HIV-uninfected mothers (p = 0.54). 97% of all mothers
were offered HTC and 96% underwent HTC during
ANC visits.
Of the HIV-infected mothers, 9 (5%) were already on
HAART before attending the ANC clinic. 100 (65%) of
the mothers not already on HAART at ANC reported
they were referred and attended (pre-) ART services at
least once, and 8 (5%) mothers initiated HAART during
pregnancy. Out of the 17 mothers on HAART during
pregnancy and delivery 15 (94%) of their infants
received sd-NVP immediately after or within 72 hours
after birth, and 8 (50%) of the mothers on HAART fol-
lowed a recommended feeding strategy.
In addition, 111 of the 164 other HIV-infected mothers
(68%) that were not yet on HAART were provided with
sd-NVP and were instructed to take it at the onset of
labor. 75% of mothers not on HAART were reported to
have taken the maternal sd-NVP at onset of or received
their dose during labor. 66% of the exposed infants were
reported to have received sd-NVP immediately or within
72 hours after birth.. Only 22 (14%) of the mothers not on
ART followed all recommended strategies meaning both
mother and infant took sd-NVP and the recommended
Table 1 Cohort Description
HIV-infected
Mothers
HIV-uninfected
Mothers
Total number of mother-child
pairs traced
360 360
Moved out of the catchment
area
37 (10%) 24 (7%)
Not found 144 (40%) 121 (34%)
Not willing to participate 3 (1%) 0 (0%)
Total mother-child pairs
included
173 (48%) 214 (59%)
Both mother/child died 5 0
Child only died 29 11
Mother only died 6 0
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feeding option was utilized. Overall among HIV-infected
mothers, 30 (18%) were able to follow all current PMTCT
recommendations.
341 of all women (91%) reported to that they knew
their HIV status before going into labor. Among the 35
women with unknown HIV status, 12 (34%) were tested
during or within 48 hours after labor.
45 (26%) HIV-infected mothers were on HAART by
18-20 months post-partum (at the time of the study)
and reported having an ART follow up visit in the last 6
months. 27 (23%) HIV-infected mothers not on HAART
reported having a pre-ART follow-up visit in the past 6
months. Of the 128 HIV-infected mothers not on ART,
56 (44%) reported not having started based on high
CD4 (WHO stage I or II). The remaining 72 HIV-
infected mothers (56%) were either never staged or had
an unknown CD4.
Among the HIV-infected mothers, 99 (61%) recalled
being told about the importance of follow up for their
exposed infants. Of all exposed infants, 47 (28%)
attended follow up for HIV-testing at least once.
HIV-infected women were more likely to opt for 6
months exclusive breastfeeding compared to HIV-unin-
fected women; 20% versus 1% respectively (p = 0.002).
HIV-infected mothers breastfed fewer months than
HIV-uninfected mothers (mean 18 vs. 12 months,
respectively; p < 0.01), and 48% of HIV-infected and
90% of HIV-uninfected mothers were still breastfeeding
at >18 months (p < 0.01). 28 HIV-infected women
started HAART post-partum at a mean of 9.5 months
into the breastfeeding period.
Table 4 shows the proportion of recommended
PMTCT strategies followed by the cohort of HIV-
infected mothers and their infants.
Maternal and Child Mortality and HIV Transmission
Table 5 shows mother and child outcomes by HIV sta-
tus. There were 11 (6.4%) maternal deaths, all among
HIV-infected women. The mean age of the child at time
of mother’s death was 10 months. Among the 5 mother-
child pairs where both died, 3 children died within
3 months after their mothers’ death; 2 children died
within 6 months prior to the death of their mothers.
Children of HIV-infected mothers were four times more
likely to have died by the time of study than those of
HIV-uninfected mothers (19% vs. 5%; RR3.9; 95%CI
2.1-7.5; p < 0.001).
Table 2 Uptake of ANC, HTC and recommended feeding options
HIV-infected (n =
173)
HIV-uninfected (n =
214)
p-
value
HTC at ANC and labor
Mean number of ANC visits (±SD) 3.7 (±1.3) 3.8 (±1.2) 0.54
Offered HTC at ANC 158/162* (97.5%) 207 (96.7%) 0.12
Uptake of HTC at ANC 154/162 (95.1%) 206 (96.3%) 0.22
Known HIV status before labor 146/162 (90.1%) 195 (91.1%) 0.23
Received HTC at or within 48 hrs after labor (If status not already known) 7/19 (36.8%) 5/16 (31.3%) 0.55
Utilization of feeding options
Avoidance of all breastfeeding from birth 3 (1.8%) 2 (0.9%)
6 months exclusive breastfeeding and NO breastfeeding after 34 (19.7%) 2 (0.9%) 0.002
Mixed feeding** started within the first 6 months 58 (33.5%) 73 (34.3%)
6 months exclusive breastfeeding and mixed feeding* from 6 months onwards. 75 (43.4%) 136 (63.8%)
Mean number months breastfed (±SD) 12.1 (± 6.4) 17.9 (± 3.4) <0.001
*162 alive HIV-infected mothers.
**Mixed feeding: breast, commercial infant formula and other.
Table 3 Uptake of antiretrovirals among HIV-infected
mother-child pairs (N = 173)
Uptake of maternal and infant sd-NVP during
pregnancy and labor
Maternal sd-NVP received at ANC by those not already
on HAART
111 (67.7%)
Maternal sd-NVP taken at onset or later in labor by
mothers not on HAART (n = 156)
117 (75.0%)
Infant sd-NVP received within 72 hours after birth 114 (65.9%)
Uptake of maternal ART
Mothers already on HAART at ANC 9 (5.2%)
Mothers started HAART during pregnancy 8 (4.6%)
Mothers that started HAART post-partum 28 (23.9%)
Mothers attended (pre-) ART follow up in past 6
months
72 (44.4%)
ART 45 (100%)
pre-ART 27 (23.1%)
Uptake of follow up for exposed infants
Alive Mothers advised about follow up for exposed
infants
99 (61.1%)
Infants followed and tested for HIV at least once at
18-20 months of age
47 (27.6%)
Exposed children tested HIV-Infected prior to the
study
7/47 (14.9%)
HIV+ children started HAART 2
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Figure 1 gives a detailed overview of the uptake of
PMTCT services and infant feeding practices utilized by
HIV-infected mothers and their infants. As part of the
decision chart mother and child outcomes, in terms of
maternal and child mortality and HIV transmission
related to the uptake of the PMTCT recommendations,
are shown by strategy followed.
HTC was offered to all HIV-uninfected mothers, 154
(72%) were tested and 4 (2.6%) new sero-conversions
were confirmed at the time of study. As 40% of the unin-
fected mothers were lost to follow, this percentage may
be an underestimation. HTC was also offered to the chil-
dren, of which 104 (75%) exposed children with unknown
status were tested and 8 new diagnoses were confirmed.
Given that 7 children were known HIV-infected prior to
the study, the total number of transmissions among
living tested children was 15 (13.5%). HIV-free infant
survival at 18-20 months among HIV-exposed was
66.2% whereas survival among HIV-unexposed infants
was 93.1%.
Discussion
This study assesses PMTCT program outcomes under
routine conditions in Zomba District and identifies
areas for improvement. Overall PMTCT effectiveness
indicated by HIV-free survival at 18-20 months was
much lower under routine program conditions than
results from study populations would suggest. Data
from the HIVNET012 trial in Uganda showed that in
the study arm that received maternal and infant sd-NVP
HIV free survival was 79.7% (95% CI 74.7-83.8) by 18
months. Our results show even lower HIV-free survival
of 66% (95% CI 58.4-74.0).
We found suboptimal use of NVP prophylaxis with
75% of mothers not on HAART taking sd-NVP at onset
or during labor and 66% of infants receiving sd-NVP
within 72 hours after birth. Similar poor uptake was
shown in Uganda, where 77% of HIV-infected pregnant
women received therapy, and 62% of the reported
exposed infants received newborn sd-NVP [10]. Poor
uptake may in part be related to an unwillingness of
mothers to reveal their HIV status, since we know that
the 14 (9%) HIV-infected mothers who denied their sta-
tus in this study were among the least likely to comply
with the recommended strategies. In concurrence,
recent qualitative studies from Malawi found that low
uptake of or dropping out of PMTCT services was
related to avoidance of involuntary HIV disclosure, fear
Table 4 Summary of uptake of recommended PMTCT strategies amongst HIV-infected mothers (N = 173)
sd-NVP at the onset of
labor
Infants given sd-
NVP*
Recommended BF option
followed**
followed all*** current PMTCT
recommendations
Mothers on HAART 17 15/16 (94%) 8/16 (50%) 8/15 (53%)
Mothers NOT on
HAART
156 117/156 (75%) 99/154 (64%) 29/154 (19%) 22/154 (14%)
Total 173 117/156 (75%) 114/170 (67%) 37/170 (22%) 30/170 (18%)
*Live-born infants only included.
**Avoidance of all breastfeeding from birth or exclusive breastfeeding for the first 6 months of life, and no breastfeeding after.
***Mothers on HAART during pregnancy and delivery AND infants received sd-NVP AND recommended feeding options were utilized; OR mothers had taken sd-
NVP at onset or during labor AND infants had received sd-NVP AND recommended feeding options were utilized.
Table 5 Maternal and Child Mortality and HIV
Transmission
HIV-infected
N = 173
HIV-uninfected
N = 214
p-
value
Maternal Deaths 11 (6.4%) 0
Mean Child’s Age
at Maternal
Death in months
(±SD)
10.3 (±4.8) 0 .
Child Deaths 34 (19.1%) 11 (5.1%) 0.0001
Child Death Type
Illness 30 (17.3%) 9 (4.2%) 0.001
.
Accident 1 (0.6%) 0 .
Stillbirth < 36
weeks
1 (0.6%) 1 (0.5%) 0.38
Stillbirth at term 1 (0.6%) 1 (0.5%)
Dead within 48
hours
1 (0.6%) 0
Mean Age at
child death in
months (±SD)
9.2 (±6.2) 7.1 (±4.9)
HIV Testing at
the time of study
Alive children
born from HIV-
infected mothers
(n = 139)
Alive children born
from HIV-
uninfected mothers
(n = 203)
Number of
children tested at
time of study
104 (74.8%) 148 (72.9%) 0.59
Total HIV
Transmissions
Known prior to
study
7 0
Tested in study
(new diagnosis)
8 0
Total 15 0
(HIV-free) survival
by 18-20 months
(95% CI)
66.2% (58.4-74.0) 93.1% (89.1-97.9) 0.0001
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of negative community reactions and lack of support
from husbands [11,12].
The results of this study suggest there was under-pre-
scription of HAART for pregnant women. Only 10% of
HIV-infected mothers were on HAART during preg-
nancy and delivery and half of those initiated HAART
during the reference pregnancy for this study. This low
percentage of women on HAART may be related to a
lack of clarity of recommendations or because staging
and CD4 counts were underperformed. Over half of the
HIV-infected pregnant women were either never staged
or had an unknown CD4 count. While this may have
contributed to potentially preventable MTCT, it is also
likely a major factor related to maternal death. Maternal
mortality among HIV-infected women was very high at
6% (equivalent to 6000 per 100000) whereas there were
no deaths among HIV-uninfected mothers.
Recommended infant feeding practices (current at that
time) were poorly adhered to as HIV-infected mothers
not on HAART breastfed on average 12 months and 48%
were still breastfeeding after 18 months. This may also be
related to lack of clarity of infant feeding recommenda-
tions, to stigma associated with not breastfeeding, and/or
to lack of safe alternatives to breast milk. Other recent
studies from Malawi, Kenya and Zambia described this
lack of clarity among health workers and the low priority
for infant feeding counseling within PMTCT programs
[11-13]. Taha and colleagues conducted a series of trials
in Malawi studying the effectiveness of NVP and combi-
nation therapy and the impact of breastfeeding on
MTCT [14-17]. For infants not infected at birth and
retested at 6 to 8 weeks, transmission was 6.5% [15,16].
By the age of 24 months, the cumulative risk of HIV
infection among infants who received short antiretroviral
prophylactic regimens and were uninfected at 1.5 months
was 9.7% [17] This suggests that even with the proper
application of sd-NVP there was likely to be significant
continued vertical HIV transmission throughout the
breast feeding period among our study population (unless
the mother was taking HAART).
Follow-up HIV testing for HIV-exposed infants was
poor. Only 28% of exposed infants were followed and
tested at least once by 18-20 months of age (prior to this
study). Recent studies from Mozambique, Kenya and
Uganda show similar low uptake and high drop out rates
of HIV-exposed infants and children for HIV diagnoses
and care [18-21]. Loss to follow up of exposed infants
and children among our study population reflects a lack
14 mothers denied HIV status  
Other*  
* (STILL BFafter
6Mo OR <6Mo excl 
BF)
7
         1 still-birth at term 
1 infant death <48hours 1 preterm infant death 
173 HIV+ 
Mother/child pairs
17 Mothers on 
HAART at delivery
156 Mothers NOT on 
HAART at delivery
117 Mothers taken NVP
at onset /during labor
39 Mothers NOT taken 
NVP at labor or unknown
34 Babies NOT given NVP 
after birth or unknown
5 Babies given NVP
within 72 hours after birth 
21 Babies NOT given NVP 
after birth or unknown
93 Babies given NVP
within 72 hours after birth 
NO BF (1) OR  
6MonthsExcl BF 
& NO BF after 
8
2 deaths (a, b)
5 live, HIV- 
13 deaths (e)
4 live, HIV+ 
11 live, not tested 
44 live, HIV- 
6 deaths (c)
(1 HIV+ death)(d)
4 live, not tested 
12 live, HIV- 
3 deaths (g)
3 live, HIV+ 
1 live, not tested 
11 live, HIV- 
1 death (f)
2 live, HIV-  
1 death (h)
2 live, not tested 
2 live, HIV- 
3 live, HIV+ 
1 live, not tested 
0 live, HIV-
4 deaths (i)
4 live, HIV+ 
11 live, not tested 
11 live, HIV-
Other*  
72 
NO BF (2) OR  
6MonthsExcl BF 
& NO BF after
22
Other*  
18 
6MonthsExcl BF 
& NO BF after 
3
Other*  
30 
6MonthsExcl BF 
& NO BF after 
4
Other*  
5
1 maternal death (I)
15 Babies given NVP
within 72 hours after birth 
8 live, HIV - 
3 maternal deaths (IV) 4 maternal deaths (V)1 maternal death (II) 2 maternal deaths (III)
c) 1 infant never breastfed, died at 7 days 
    1 infant died at 3Mo, 1 at 9Mo, 3 between12-20Mo 
d)  HIV+ child died at 14 Mo 
e) 2 infants died <6Mo, 6 between 6-12Mo, 5 between 
12-20Mo 
I) mother died at 11Mo child age; child HIV-.  
II) mother died at 11Mo after birth; infant died at 7Mo.
f) infant died at 7Mo 
g) 3 children died between 10-15Mo 
h) infant died at 12 days 
III) 1 mother died at 14Mo child age; child died at 15Mo     
.    1 mother died at 17Mo after birth; child died at 10Mo 
 (i) 2 infants died at 1 Mo, 1 at 2Mo, 1 at 12Mo 
IV) 3 mothers died at child age 10, 12, 19 Mo;  
      2 live HIV+, 1 live not tested  
V) 2 mothers died at child age 4 and 11 Mo; both  
children live, HIV-. 1 mother died at 9Mo child age; 
child died at 12Mo. 1 mother died 3 Mo after birth, 
child died at 1Mo 
a) ART from conception, infant died at 5 days. 
b) ART from conception, stopped BF at 4Mo,     
child died at 10Mo.  
Figure 1 PMTCT uptake, infant feeding practices and mother-child outcomes.
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of systematic follow-up by health facilities as well as
some lack of knowledge or denial of the importance of
infant follow-up among HIV-infected mothers.
The most striking finding of this study is that among
all HIV-infected mothers, only 18% were able to follow
all current PMTCT recommendations. Other studies
have shown similar low coverage of PMTCT services in
sub-Saharan Africa [22-24]. Partner and community
involvement have been described as strategies for
improving this low coverage [10-12]. New and innova-
tive research is needed to inform programmers about
barriers and facilitators to uptake of PMTCT services
and safe infant feeding options. Improved HIV-free
infant survival, and improved maternal survival, may be
achieved by optimizing initiation of HAART during preg-
nancy and breastfeeding [25,26]. Improved post-natal fol-
low-up could better support mothers in adhering to safe
infant feeding options to minimize post-natal vertical
HIV transmission and also allow for timely diagnosis of
infants who acquire HIV infection despite PMTCT inter-
ventions, or when none were implemented.
In 2011, the Malawi MoH is planning a test and treat
strategy to optimize delivery of HAART during preg-
nancy and breastfeeding as recommended in the revised
WHO guidelines (Option B plus lifelong HAART), and
the results of this study provide strong local evidence to
support these plans. The low compliance we observed
with a relatively simple PMTCT intervention such as sd-
NVP suggests that uptake of maternal HAART during
pregnancy and the breastfeeding period is likely to face
similar or potentially greater challenges (due to the regi-
men’s greater complexity) in its programmatic applica-
tion. Concurring, Rollins and colleagues who studied the
effect of health systems performance on rates of MTCT
concluded recently that the introduction of more effec-
tive combination ART interventions will yield only mar-
ginal reductions in childhood HIV infections and
mortality unless health systems achieve high levels of
performance at each step of the PMTCT pathway [27].
Conclusion
This study shows low PMTCT program efficiency and
effectiveness under routine program conditions in
Malawi. PMTCT effectiveness indicated by HIV-free
survival at 18-20 months was much lower under routine
program conditions than results from study populations
would suggest.
Maternal mortality among HIV-infected women was
high and demands further attention as improved mater-
nal survival is also a means to improve infant survival.
Improved HIV-free infant survival, and improved mater-
nal survival, may be achieved by optimizing initiation of
HAART during pregnancy and breastfeeding. Further
operational research is needed to examine the
institutional and maternal factors that influence the
uptake of PMTCT services and maternal ART. Failures
at various points in the PMTCT cascade may be asso-
ciated with avoidable MTCT
Limitations of the study
This study was limited to the cohort of women that
were identified through health centre registers, and
therefore had had at least one potential interaction with
formal PMTCT services. Our exclusion criteria excluded
women registered only at tertiary referral centres and it
is possible that these women had different characteris-
tics than our study population (e.g. urban, wealthier,
high risk obstetrical problems). Some information could
not be verified (e.g. infant feeding options utilized) and
was based on maternal recall only. Finally, when tracing
women to their homes, interviewers were not always
able to be accompanied by a HTC counselor for testing
resulting in a lower proportion of women and infants
tested. Mothers and children were subsequently referred
to the health centre for HTC, but these results were not
available for inclusion in the study.
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